Research Antibodies Market was valued at USD 5.60 Billion in 2025. Sales are expected to reach USD 6.05 Billion in 2026 and USD 13.19 Billion by 2036. Primary is poised to lead by Product Type with 61.0% share in 2026 and Monoclonal Antibodies is estimated to command by Type with 66.0% share in 2026.